Home » Teva Seeks Women’s Health-Care Market Beyond Fertility

Teva Seeks Women’s Health-Care Market Beyond Fertility

January 9, 2013

Teva Pharmaceutical plans to boost work in women’s health beyond fertility as it narrows its branded-drug focus amid competition to its best-selling medicine, CEO Jeremy Levin said.
Bloomberg

05Aug
Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management
10Aug
Is Biosimilars Regulation Taking a Major Turn?: The Latest Must-Know Developments, Including BsUFA III
12Aug
On-Site Inspections: They’re Back — But When, Where and How
28Sep
4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit
18Oct
MAGI's Clinical Research vConference — Fall 2021

Teva Seeks Women’s Health-Care Market Beyond Fertility

Upcoming Events

Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management

Is Biosimilars Regulation Taking a Major Turn?: The Latest Must-Know Developments, Including BsUFA III

On-Site Inspections: They’re Back — But When, Where and How

4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit

MAGI's Clinical Research vConference — Fall 2021

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

Shionogi Begins Human Trials of First Once-A-Day Pill for COVID-19 Patients

Becton Dickinson’s Vacutainer Gets EUA for COVID-19

BioNTech to Develop the First mRNA-Based Vaccine for Malaria Prevention

Gnomon Informatics Gets CE Mark for Medical Device Software

The Revised ICH E8: A Guide to New Clinical Trial Requirements